Vanguard Group Inc Casi Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$1.48 - $2.79 $259 - $488
175 Added 0.07%
257,618 $461,000
Q3 2022

Nov 14, 2022
SELL
$2.36 - $4.69 $114,906 - $228,351
-48,689 Reduced 15.9%
257,443 $669,000
Q2 2022

Aug 12, 2022
BUY
$2.85 - $7.1 $872,476 - $2.17 Million
306,132 New
306,132 $875,000

Others Institutions Holding CASI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CASI Pharmaceuticals, Inc.

CASI Quotes by TradingView
  • Ticker CASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,606,100
  • Market Cap $36.5M
  • Description
  • CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patien...
More about CASI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email